Key facts
- This page summarizes Seth Lederman's Form 4 filing for Tonix Pharmaceuticals Holding Corp. (TNXP).
- 2 reported transactions and 2 derivative rows are listed below.
- Accepted by SEC: 26 Feb 2026, 07:01.
Seth Lederman - 24 Feb 2026 Form 4 Insider Report for Tonix Pharmaceuticals Holding Corp. (TNXP)
- Reporting relationship
- Chief Executive Officer, Director
- Issuer ticker
- TNXP
- Reported as of
- 24 Feb 2026
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 26 Feb 2026, 07:01:33 UTC
- Prior SEC filing
- 15 May 2025
- Next SEC filing
- 18 Mar 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ Seth Lederman
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Seth Lederman filed Form 4 for Tonix Pharmaceuticals Holding Corp. (TNXP) on 26 Feb 2026.
Change
- Previous filing in this sequence was filed on 15 May 2025.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001563420
Primary reporting owner
LEDERMAN SETH
- Relationship
- Chief Executive Officer, Director
- Address
- C/O TONIX PHARMACEUTICALS HOLDING CORP, 200 CONNEL DRIVE, SUITE 3100, BERKLEY HEIGHTS
- Signature
- /s/ Seth Lederman
- Signature date
- 26 Feb 2026
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
TNXP
transaction
Derivative
Stock Option
Award
- Transaction value
- $0
- Shares
- +134,504
- Change %
- Price
- $0.000000
- Shares after
- 134,504
- Date
- 24 Feb 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 134,504
- Exercise price
- $14.29
- Footnotes
- F1, F2
TNXP
transaction
Derivative
Stock Option
Award
- Transaction value
- $0
- Shares
- +134,503
- Change %
- Price
- $0.000000
- Shares after
- 134,503
- Date
- 24 Feb 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 134,503
- Exercise price
- $17.86
- Footnotes
- F1, F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
One-third of the option vests on the first anniversary of issuance and 1/48th each month thereafter for 36 months.
Footnote F2
The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan, as amended.